Looking at the Nifty and Nifty Junior and some interesting setups.
PFC – Finally has crossed 90-92 resistance. Stoploss 85 Upside possibility 125
Divis Labs – Only large cap pharma to cross 2016 highs.
Aurobindo Pharma – Knocking on 800-820 resistance.
ICICI Bank – 360-370 a major resistance for last 2-3 years. Can it cross and rally hard over the next year or so ?
320 a support and now seems a buy on dips with sl of 295
Do read our older post - http://www.nooreshtech.co.in/2018/09/smallcap-index-cycles-2005-2018-its-darkest-before-dawn.html
We are hopeful on a whole lot of midcap/smallcap/largecap companies which can do well over the short term as well as long term.
What we did last time in 2013-2014 is started with customized advisory for select HNI clients in Platinum Plus as it seemed one of the good times to increase equity exposure. Its been fruitful for all of us.
Most advisers tend to pitch their products after a solid performance but we believe after a short term bad performance by us along with the bad markets is a better time to pitch our products and to meet prospective clients who would be interested for long term advisory relationships. As such relationships last longer and are fruitful for all of us.
If you are interested in our advisory services -
For more details Call - Nooresh Merani – 9819225396.
drop down to meet with prior appointment. Am based out of Andheri West – Mumbai.
Our other services
Can subscribe to The Agnostic Portfolio ( Its down 20-25% since the launch in mid April) . A lot of stocks have now come to valuations where its tough to not make money over the next 1-2 years. We will be extending subscription periods for existing clients in Agnostic given the relative underperformance.
For Derivatives - http://www.nooreshtech.co.in/quickgains
The product is for traders with a High RIsk Profile and High Risk Apetite. Holding period of positions is 1-15 sessions generally.
For customized Advisory Services for HNIS – Call Nooresh Merani 9819225396 or mail email@example.com
DISCLOSURE Nooresh Merani
Securities covered above: All mentioned in the above post
SEBI Registration disclosure - Investment Adviser ( INA000002991)
Nooresh Merani and his family/associates/ analysts would not have exposure in the securities mentioned in the above report/article.
Nooresh Merani and his family/associates/ analysts do not have any financial interest/beneficial ownership of more than 1% in the company covered by Analyst.
Nooresh Merani and his family/associates/ analysts have not received any compensation from the company/third party covered in the above report/article ever.
Nooresh Merani and his family/associates/ analysts has not served as an officer, director or employee of company covered in the report/article and has not been engaged in market-making activity of the company covered in the report/article.
The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision
Also read the detailed disclaimer - http://www.nooreshtech.co.in/disclaimer